Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells

Journal of the National Cancer Institute
Y KangR R Perry

Abstract

The antiestrogen tamoxifen (TAM) is effective in the treatment of estrogen receptor (ER)-positive as well as some ER-negative breast cancers. However, the precise mechanism of action of TAM, especially in estrogen-independent cells, remains unclear. Previous work by our laboratory has demonstrated that TAM induces the morphologic and biochemical changes that are characteristic of apoptosis in both ER-positive and ER-negative cells. We compared the effect of TAM at a clinically achievable concentration on cell growth and apoptosis with the effect of TAM on c-myc (also known as C-MYC) messenger RNA (mRNA) and protein expression in ER-negative MDA-231 cells. MDA-231 cells were treated for up to 72 hours with 1.0 microM TAM alone or in the presence of 50 microM c-myc antisense or nonsense oligonucleotides. c-myc mRNA expression was determined by northern blot analysis, protein expression by western blot analysis, cell growth inhibition counts, and DNA cleavage by agarose gel electrophoretic analysis. Differences between the mean values from different treatment groups were compared with the use of the two-sided Wilcoxon Ranksum test. TAM treatment for 72 hours increased c-myc mRNA five-fold (from a relative radiolabeled hybridizatio...Continue Reading

Citations

Apr 13, 2010·Cancer Chemotherapy and Pharmacology·Valentina K TodorovaV Suzanne Klimberg
Mar 19, 2008·Journal of Cancer Research and Clinical Oncology·Adam D Elkin, Charlotte D Jacobs
Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·N Hail
Jul 26, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shigehira Saji, Katsumasa Kuroi
May 1, 1997·Breast Cancer Research and Treatment·S J Nass, R B Dickson
May 6, 2004·Journal of the National Cancer Institute·Shi-Yong SunReuben Lotan
Jun 23, 2000·Journal of Pediatric Hematology/oncology·A W WalterR L Heideman
Jul 9, 1999·Journal of Clinical Pathology·S M Ismail
Aug 29, 2003·The American Journal of Chinese Medicine·Jung-Chou ChenKuei-Chu Chen
Dec 11, 2013·European Journal of Medicinal Chemistry·Makoto HasegawaTamio Mizukami
Oct 7, 2003·Oncogene·Annamaria BiroccioGabriella Zupi
Jun 23, 1999·Oncogene·G C Prendergast
Feb 4, 2005·Journal of Neuro-oncology·Yong-Jung KimYoung-Mi Yoo
Dec 31, 2008·Journal of Cellular Biochemistry·Paola SearovicClaudia G Saez
May 31, 2002·Expert Opinion on Pharmacotherapy·Banu ArunBarbara Dunn
Aug 1, 1997·Endocrinology·B SukhuH C Tenenbaum
Mar 5, 2019·Biological & Pharmaceutical Bulletin·Takumi IwasawaYukitoshi Nagahara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis